Cutting down, quitting and motivation to stop smoking by self-reported COVID-19 status: Representative cross-sectional surveys in England.

"after internal review we ran a sensitivity analysis where we included strength of urges to smoke (a known marker of tobacco dependence and relapse [ ) as an additional covariate ( https://osf io/h5qf8 ).; bayes factors (bf) for non-significant results are available on-line ( https://osf io/h5qf8 )."

"DECLARATION OF INTERESTS S.C., H.T.B., S.E.J. and L.D. have no competing interests. J.B. has received unrestricted research funding to study smoking cessation from manufacturers of smoking cessation medications (Pfizer and Johnson & Johnson). L.S. is a HEFCE‐funded member of staff at University College London. He has received honoraria for talks, an unrestricted research grant and travel expenses to attend meetings and workshops from Pfizer and an honorarium to sit on advisory panel from Johnson & Johnson, both pharmaceutical companies that make smoking cessation products."

"This study was supported by a grant from Cancer Research UK PRCRPG‐Nov21\100002. The authors are members of SPECTRUM, a UK Prevention Research Partnership consortium, funded by UK Research and Innovation Councils, the Department of Health and Social Care (England), and the UK devolved administrations and leading health research charities (MR/S037519/1)."